Yazar "Guvenc, S." için listeleme
-
ALLOGENEIC RELATED DONOR STEM CELL TRANSPLANTATION IN AML CR1: ANY RISK FACTOR FOR BETTER SURVIVAL?
Guvenc, S.; Ozcelik, E.; Hindilerden, F.; Hasbal, N.; Serefhanoglu, S.; Kucukkaya, R.; Arat, M. (NATURE PUBLISHING GROUP, 2014)… -
A NOVEL ADAMTS13 MUTATION IN THROMBOTIC THROMBOCYTOPENIC PURPURA PRESENTED IN AN OLD PATIENT
Guvenc, S.; Hancer, V.; Hindilerden, F.; Diz-Kucukkaya, R. (Ferrata Storti Foundation, 2012)[No abstract available] -
TET2 MUTATIONS IN ESSENTIAL THROMBOCYTHEMIA AND PRIMARY MYELOFIBROSIS
Turan, C.; Guvenc, S.; Hancer, V. S.; Hindilerden, F.; Arat, M.; Kucukkaya, R. (FERRATA STORTI FOUNDATION, 2015)… -
TWO NOVEL CALRETICULIN MUTATIONS IN A TURKISH PATIENT WITH PRIMARY MYELOFIBROSIS: C.1116DELA AND C.1120A > C
Guvenc, S.; Hancer, V. S.; Uslu, N.; Arat, M.; Kucukkaya, R. (FERRATA STORTI FOUNDATION, 2015)… -
USE OF ELTROMBOPAG IN IMMUNE THROMBOCYTOPENIA IN TURKEY
Cekdemir, D.; Ozdemirkiran, F.; Guvenc, S.; Eser, A.; Ozkocaman, V.; Sahin, H. H.; Kucukkaya, R. D. (PERGAMON-ELSEVIER SCIENCE LTD, 2016)…